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Abstract: IL-10 and TNF- are cytokines that have complex and opposing roles in the inflammatory responses. G/A po-
lymorphisms at position –1082 of IL10 and –308 of TNFA genes have been reported to influence the expression of IL-10 
and TNF-, respectively. The aim of this study was to investigate the association between the IL10 (-1082) and TNFA (-
308) gene polymorphisms with different clinical forms or severity of periodontitis in a sample of Brazilian individuals. 
DNA was obtained from oral swabs of 165 Brazilian individuals, which were divided into three groups: individuals with 
chronic periodontitis, aggressive periodontitis and individuals without clinical evidence of periodontitis. Evaluation of 
IL10 and TNFA polymorphisms was performed by RFLP analysis. Statistical analysis of data was performed using the 
2 
likelihood ratio and Fisher`s exact test. No significant differences in the genotype and allele distribution of either IL10 or 
TNFA were observed among individuals with different clinical forms or with different degrees of severity of periodontitis. 
Moreover, combined analysis of IL10 and TNFA polymorphisms did not show any association with periodontal status. As 
conclusion, the IL10 and TNFA gene promoter polymorphisms investigated are not associated with different clinical forms 
of periodontitis or with severity of the disease in the Brazilian population polymorphisms.   
Keywords: IL-10, TNF-alpha, periodontitis, polymorphism. 
INTRODUCTION 
Periodontitis is a multifactorial polymicrobial infection 
characterized by an inflammatory process that leads to de-
struction of teeth supporting tissues [1]. There is a complex 
network of pro- and anti-inflammatory cytokines acting in 
the inflamed periodontal tissues [2, 3]. Tumor necrosis fac-
tor-alpha (TNF-), a pro-inflammatory cytokine, has been 
detected in gingival crevicular fluid and gingival tissues 
from individuals with periodontitis [4, 5]. This cytokine is a 
potent immunologic mediator that, in addition to its inflam-
matory effects, increases bone resorption and regulates fi-
broblast proliferation [6, 7]. TNF- activity is regulated by 
interleukin-10 (IL-10) and other anti-inflammatory mole-
cules. IL-10 has the ability to block cytokine synthesis, as 
well as several accessory cell functions [8] and also may 
contribute to the regulation of cell proliferation and differen-
tiation [9]. The balance between these and other cytokines 
regulate the homeostasis of the immune system. Thus, in an 
inflammatory disease, the predominance of pro-inflam-
matory cytokines is expected, leading to an unbalanced re-
sponse and further tissue destruction [10]. 
The presence of functional polymorphisms in cytokine 
genes affects cytokine expression and thus may have an im-
portant role in the genetic regulation of inflammatory re-
sponse and of resistance or susceptibility to infections, such  
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as periodontal disease [11-13]. The gene encoding TNF- 
has been mapped to chromosome 6 and a polymorphism in 
the locus –308, causing a substitution from the guanine (G) 
to adenine (A), leads to two- to threefold higher transcrip-
tional activity of TNF- upon stimulation with bacterial 
lipopolysaccharide [14]. The gene encoding IL-10 is mapped 
to chromosome 1 and displays a polymorphism within the 
promoter region at position –1082 (also referred to as -1087), 
being composed of a G to A substitution [15]. This polymor-
phism lies within as ETS-like recognition site [16] and may 
affect the binding of this transcription factor producing a 
higher IL-10 protein levels in GG individuals [15].  
Considering the importance of TNF- and IL-10 in the 
dynamics of inflammatory responses and, thus, in the patho-
genesis of periodontitis, and that the presence of functional 
polymorphisms in TNFA and IL10 genes affect the levels of 
expression of these cytokines, the aim of this study was to 
evaluate the association between the occurrence of the IL-10 
(-1082) and TNFA (-889) gene polymorphisms in a sample 
of Brazilian patients with different clinical forms periodonti-
tis, as well as with different degrees of disease severity.  
MATERIALS AND METHODOLOGY 
Patients 
The study employed a cross-sectional design involving 
individuals from the State of Minas Gerais from the South-
eastern region of Brazil. A total of 165 patients receiving 
treatment at the Dentistry School, Federal University of Mi-
nas Gerais, were included in this study. The patients were 
stratified into three groups: subjects with aggressive perio-IL10 and TNFA Polymorphisms in Brazil  The Open Dentistry Journal, 2009, Volume 3    185 
dontitis (AP, n=55), subjects with chronic periodontitis (CP, 
n=67) and healthy volunteers, without clinical evidence of 
periodontitis, as the control group (C, n=43). All patients 
came from the same geographical area, had a similar socio-
economic status, and displayed no significant differences in 
the ratio of men to women, or age, between the groups. Pa-
tients in the AP group were 15-46 years old and exhibited 
highly destructive forms of periodontitis; in these patients, 
the amount of microbial deposits did not justify the severity 
of periodontal tissue destruction. Patients in the CP group 
were 25-67 years old and exhibited loss of clinical attach-
ment and amount of destruction consistent with the presence 
of local factors. Individuals with more than three sites with a 
probing depth of >5mm and lesions distributed on more than 
two teeth in each quadrant, were included in this group. No 
case that produced doubt in classification was included in the 
study. Diagnosis of disease was made considering the pa-
tient’s medical and dental histories, radiographic findings 
and observation of clinical signs and parameters including 
probing depth, assessment of clinical attachment loss (CAL), 
observation of tooth mobility, bleeding on probing and pres-
ence of plaque/calculus. Clinical diagnosis of periodontitis 
was based on criteria established in 1999 at the International 
Workshop for a Classification of Periodontal Diseases and 
Conditions [17]. Measurements of probing depth and CAL 
were assessed at six locations around each tooth. The sever-
ity of disease was characterized on the basis of the mean of 
CAL, within each clinical form. Assessment of CAL was 
performed by insertion of a periodontal probe in the gingival 
sulcus and the measurement corresponding to the distance 
from the cemento-enamel junction to the location of a perio-
dontal probe tip was defined as CAL. Results were expressed 
as mean CAL; that is, the average of CAL in all six sites of 
the affected teeth. Patients exhibiting CAL5mm were con-
sidered with severe and those exhibiting 3mm  CAL>5mm 
were considered with moderate periodontitis, as previously 
used by us [18]. Healthy control individuals included in 
study were 20-70 years old and did not have, at the time of 
sample collection, periodontal disease; as determined by 
absence of sites with probing depth >3mm. Moreover, upon 
questionnaire and clinical evaluation control individuals did 
not have history of periodontal disease.  Measurements of 
probing depth and clinical attachment loss were assessed at 
six locations around each tooth in all the individuals in-
volved in present study. 
A questionnaire was applied to all individuals enrolled in 
this study, in order to obtain information regarding dental 
history, family history of periodontal disease, smoking habit, 
as well as general health concerns. Use of orthodontic appli-
ances; chronic use of anti-inflammatory drugs; history of 
diabetes, hepatitis or HIV infection; immunosupressive che-
motherapy; bleeding disorders; severely compromised im-
mune function; pregnancy or lactation were regarded as ex-
clusion criteria. Except for the presence of periodontitis, the 
patients included in this study were systemically healthy. 
Because tobacco smoking is an important risk factor for pe-
riodontitis, we also analyzed our data taking the habit of 
smoking under consideration. “Smokers” were defined as 
current smokers/former smokers (more than ten ciga-
rettes/day) and “non-smokers” included individuals that had 
never smoked. Table 1 summarizes the patient data, as well 
as their classification into different groups.  
This study was approved by Universidade Federal de 
Minas Gerais’s Ethics Committee (nº 003/03) and a signed 
informed consent was obtained from all participants.  
Sample Collection and DNA Extraction 
Epithelial cells were obtained through an oral swab per-
formed with a sterile plastic spatula and placed in 1500μl of 
Krebs buffer (NaCl 20%, KCl 2%, CaCl2  2%, H2O 2%, 
MgSO4, KH2PO4, C6H12O6). DNA extraction was performed 
as described previously by us [18]. A pellet of cells was ob-
tained, the supernatant was removed, 20μl of silica (SiO2, 
Sigma, St. Louis-USA) and 450μl of lyses buffer (6,0M 
GuSCN, 65mM Tris-HCl pH=6,4, 25mM EDTA and 1,5% 
Triton X-100) were added to the microtubes. Samples were 
homogenized and incubated for 30 min at 56ºC. After an-
other centrifugation, the pellet obtained was washed twice 
with 450μl washing buffer (6,0M GuSCN, 65mM Tris-HCl 
pH=6,4), twice with 450μl of 70% ethanol, once with 450μl 
acetone and dried at 56ºC for 20 min. Finally, 100μl of TE 
buffer (10mM Tris-HCl pH=8,0 and 1mM EDTA) was 
added and incubated at 56ºC for 12 h. After incubation, the 
Table 1. Characteristics of the Study Groups 
Clinical Forms  Control (C) 
Aggressive 
Periodontitis (AP) 
Chronic 
Periodontitis (CP) 
Number of individuals (n)  43  55  67 
Age range  (years)  20-70  15-46  25-67 
Gender 
male (%) 
female (%) 
 
17 (39.5) 
26 (60.5) 
 
20 (36.4) 
35 (63.6) 
 
20 (29.8) 
47 (70.2) 
CAL (mm) 
mean (±SD) 
 
- 
 
6.17 ± 1.57 
 
5.69 ± 1.22 
Smoking status 
Non-smokers (%) 
Smokers (%) 
 
39 (90.7) 
4 (9.3) 
 
36 (65.5) 
19 (34.5) 
 
38 (56.7) 
29 (43.3) 186    The Open Dentistry Journal, 2009, Volume 3  Moreira et al. 
solution was homogenized, centrifuged and the supernatant 
containing DNA obtained.  
Polymerase Chain Reaction (PCR) and Restriction En-
donuclease Digestion  
IL-10 (-1082) and TNFA (-308) polymorphisms were as-
sessed by standard polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) assay. The se-
quences of PCR primers used were 5’CCAAGACAACAC-
TACTAAGGCTCCTTT3’and 5’GCTTCTTATATGCTAGT 
CAGGTA3’ with expected PCR product size of 377bp to 
IL10 polymorphism [19] and 5’AGGCAATAGGTTTT 
GAGGGCCAT3’ and 5’TCCTCCCTGCTCCGATTCCG3’ 
with expected PCR product size of 107bp to TNFA 
polymorphism [20]. PCR was carried out in a total volume 
of 50μl, containing 10μl of solution DNA, Pre-mix buffer 
(Phoneutria Biotecnologia-Brazil) and primers (20 pMol/ 
reaction). The amplification conditions consisted of 94ºC for 
conditions consisted of 94ºC for 3 min followed by 40 cycles 
of 94ºC for 30s, 56ºC for 35s and 72ºC for 30s, and final 
elongation at 72ºC for 5 min for both primers used. The 
products were digested with 5 units of enzyme at 37ºC for 4 
hours. For IL-10 polymorphism was used XagI  enzyme 
(MBI Fermentas) and digestion products of 280+97 bp and 
253+27 bp were obtained for A and G alleles, respectively. 
For TNFA polymorphism was used NCoI enzyme (Promega-
USA) and digestion products of 107 bp and 87+20 bp were 
obtained for A and G alleles, respectively. The visualization 
was performed in a 10% acrylamide gel electrophoresis, 
stained with silver. 
Statistical Analysis 
Statistical analysis of data was performed using the JMP 
statistical software (SAS, Cary, NC, USA). The 
2 likelihood 
ratio was used to compare the genotypes distributions be-
tween C and CP groups, between C and AP groups, and be-
Table 2. Distribution of the TNFA (-308) and IL10 (-1082) Genotypes in the Study Groups 
Genotype  Control (C)  Aggressive Periodontitis (AP)  Chronic Periodontitis (CP) 
TNFA (-308) Non-smokers 
GG (%)  28 (71.8)  24 (66.7)  23 (60.5) 
GA (%)  11 (28.2)  12 (33.3)  14 (36.9) 
AA (%)  -  -  1 (2.6) 
A+ (%)  11 (28.2) 12  (33.3) 15  (39.5) 
A - (%)  28 (71.8) 24  (66.7) 23  (60.5) 
TNFA (-308) Non-smokers +Smokers 
GG (%)  29 (67.4)  40 (72.7)  44 (65.7) 
GA (%)  14 (32.6)  15 (27.3)  22 (32.8) 
AA (%)  -  -  1 (1.5) 
A+ (%)  14 (32.6) 15  (27.3) 23  (34.3) 
A-  (%)  29 (67.4) 40  (72.7) 44  (65.7) 
IL10 (-1082) Non-smokers 
GG (%)  5 (12.8)  3 (8.3)  4 (10.6) 
GA (%)  19 (48.7)  15 (41.7)  17 (44.7) 
AA (%)  15 (38.5)  18 (50)  17 (44.7) 
G+ (%)  24 (61.5)  18 (50)  21 (55.3) 
G - (%)  15 (38.5)  18 (50)  17 (44.7) 
IL10 (-1082) Non-smokers + Smokers 
GG (%)  7 (16.3)  4 (7.3)  8 (11.9) 
GA (%)  20 (46.5)  25 (45.4)  28 (41.8) 
AA (%)  16 (37.2)  26 (47.3)  31 (46.3) 
G+ (%)  27 (62.8) 29  (52.7) 36  (53.7) 
G-  (%)  16 (37.2) 26  (47.3) 31  (46.3) 
* The differences among groups were not significant as analyzed with 
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tween CP and AP groups (3 x 2 contingency table, degrees 
of freedom (d.f.)=2). The G/A allele and G+/G- or A+/A- 
genotype distribution between C and CP groups, between C 
and AP groups, and between CP and AP groups were as-
sessed in 2 x 2 contingency table (df=1), as well as the com-
parisons regarding severity and “inflammatory/anti-
inflammatory” genotypes. Fisher`s exact test was performed 
in analysis of the 2 x 2 contingency table. The study groups 
were tested for Hardy-Weinberg equilibrium comparing the 
expected with the observed genotypes frequencies for both 
polymorphisms. To exclude the possible confounding effect 
of smoking, in a second analysis we excluded smokers from 
all the different clinical groups. A p-value <0.05 was consid-
ered statistically significant.  
RESULTS 
The genotype and allele distributions of the TNFA (-308) 
and IL10 (-1082) polymorphisms are shown in Table 2 and 
3, respectively. The evaluation of the genotype and allele 
distributions were performed comparing patients with differ-
ent clinical forms of periodontitis and individuals without 
clinical evidence of disease, considering or not the habit of 
smoking. With regards to TNFA (-308) polymorphism, the 
frequency of homozigous individuals to allele A was very 
low (0.61%) in the studied population. Only one individual 
out of all displayed this genotype. No significant difference 
in the genotype and allele distributions was observed among 
groups, considering or not the habit of smoking (Tables 2 
and 3). The presence of the TNF- high-producer allele in 
the population, as evaluated by the frequency of A+ indi-
viduals, showed that the frequency of A+ versus A- indi-
viduals between the groups was not significantly different 
when analyzing non-smokers, nor when smokers were in-
cluded (Table 2).  
With regards to IL10 (-1082) polymorphism, no signifi-
cant difference in the genotype and allele distributions was 
observed among groups, considering or not the habit of 
smoking (Tables 2 and 3). The presence of the IL-10 high-
producer allele in the population, as evaluated by the fre-
quency of G+ individuals, showed that the frequency of G+ 
versus G- individuals between the groups was not signifi-
cantly different when analyzing non-smokers, nor when 
smokers were included (Table 2). 
We also performed an additional analysis evaluating the 
expression of TNF- and IL-10 polymorphisms, characteriz-
ing what we defined as “inflammatory” and “anti-inflam-
matory” genotypes. Inflammatory genotype was defined as 
individuals expressing the alleles consistent with high TNF-
 and low IL-10 (A+ and G-, respectively) while anti-
inflammatory was defined as individuals expressing the al-
leles consistent with low TNF- and high IL-10 (A- and G+, 
respectively). No association was observed between these 
combined genotypes and the clinical forms of periodontitis 
analyzed (Fig. 1).  
With regards to severity of periodontitis evaluated by 
stratification of the groups according to CAL, no difference 
was observed between the groups and the occurrence of each 
polymorphism individually or of combined genotypes (data 
not shown).  
Table 3. Distribution of the TNFA (-308) and IL10 (-1082) Alleles in the Study Groups 
Allele Control  (C) 
Aggressive 
Periodontitis (AP) 
Chronic 
Periodontitis (CP) 
TNFA (-308) 
Non-smokers 
G (%)  67 (85.9)  60 (83.3)  60 (78.9) 
A (%)  11 (14.1)  12 (16.7)  16 (21.1) 
Non-smokers +Smokers 
G (%)  72 (83.7)  95 (86.4)  110 (82.1) 
A (%)  14 (16.3)  15 (13.6)  24 (17.9) 
 
IL10 (-1082) 
Non-smokers 
G (%)  29 (37.2)  21 (29.2)  25 (32.9) 
A (%)  49 (62.8)  51 (70.8)  51 (67.1) 
Non-smokers + Smokers 
G (%)  34 (39.5)  33 (30)  44 (32.8) 
A (%)  52 (60.5)  77 (70)  90 (67.2) 
* The differences among groups were not significant as analyzed with 
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DISCUSSION 
Strong evidences supports that genes play a role in the 
pathogenesis of periodontal disease [12] and the observation 
that genetic polymorphisms may be associated with the es-
tablishment of distinct immune responses to microbial infec-
tions has enhanced the interest in identifying genetic poly-
morphisms associated with diseases [21].  
Some studies evaluating the occurrence of polymor-
phisms in genes of IL-10 and TNF were performed in 
individuals with periodontal disease in different populations. 
With regards to IL-10 polymorphism, in general a lack of 
association between the IL-10 polymorphisms and periodon-
titis has been reported [22-24]. In our study, we also did not 
find an association of -1082 polymorphism of this gene with 
the susceptibility to chronic periodontitis or aggressive pe-
riodontitis, or with the severity of disease. In the literature, 
an association between the –1082 polymorphism and perio-
dontal disease were found in Caucasian individuals of a 
northern European [25] and in Egyptian individuals [26]. 
These contradictory results can be explained on the basis of 
racial difference or association with other interactive types of 
cytokines or genetic markers predisposing for the disease in 
the population evaluated, as reported by Settin et al. (2006) 
[26].  
In our study, the organization of the sample of Brazilian 
individuals into ethnic groups was not performed due to the 
strong miscegenation present among Brazilians, and based 
on the fact that classification into ethnic groups according to 
physical appearance is of little use in this population. It has 
been clearly demonstrated that Brazilian individuals classi-
fied as “white” or “black” have significantly overlapping 
genotypes, likely due to miscegenation [27]. Thus, perform-
ing additional analysis of these polymorphisms considering 
race is of questionable value. In our study, all the patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Analysis of combined genotypes concerning TNFA (-308) and IL10 (-1082) polymorphisms in the different study groups. Individu-
als with the A+ genotype of the TNFA (-308) polymorphism are classified as “high TNF- alpha producers” and individuals with the A- geno-
type are classified as “low TNF- alpha producers”. Individuals with the G+ genotype of the IL10 (-1082) polymorphism are classified as 
“high IL-10 producers” and individuals with G- genotype are classified as “low IL-10 producers”. The “anti-inflammatory genotype” con-
tains individuals classified as “low TNF- alpha and high IL-10” producers (A-/G+ for TNF- alpha and IL-10, respectively) and the “inflam-
matory genotype” contains individuals classified as “high TNF-alpha and low IL-10” producers (A+/G- for TNF-  and IL-10, respectively). 
Black bars (positive) represent individuals with the “inflammatory” or “anti-inflammatory” genotypes in respective graphs. Clear bars (nega-
tive) contain individuals that do not bear the specific combinations defined as “inflammatory” or “anti-inflammatory” genotypes. The clear 
bars in “inflammatory” graphs contains individuals with the genotypes (A+/G+ and A-/G- for TNF-alpha/IL-10) and in the “anti-
inflammatory” graph, individuals that express A+/G+ and A+/G- for TNF-alpha/IL-10. No statistical difference was observed among groups, 
considering or not the habit of smoking (2 test, 3 x 2  contingency tables). C= Control, AP= aggressive periodontitis, CP= chronic periodon-
titis. 
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and controls were selected from the same geographic area 
and were at the same socio-economic status. 
Considering possible haplotypes, each polymorphism 
may contribute to the production of IL-10 differently and 
specific haplotypes may influence in progression of perio-
dontal disease [28, 29]. IL10 promoter SNP and haplotype 
frequencies in different populations have demonstrated that 
these polymorphisms exhibit a different distribution accord-
ing to ethnicity [30-33]. The same disease may have differ-
ent contributing factors in one ethnic group compared with 
another, as certain polymorphisms may exist in one ethnic 
group but not in others [34]. With regards to the Brazilian 
population, association was observed between specific 
haplotypes in the IL-10 gene and the susceptibility to chronic 
periodontitis in patients from Piracicaba/SP-Brazil [35]. 
However, the authors verified no association with the –1082 
polymorphism; as observed in our study. Thus, although we 
did not find association of periodontitis with the polymor-
phism evaluate, other polymorphisms in IL10 gene may be 
present and the possible haplotypes may contribute to the 
production of IL-10 differently.  
With regards to TNFA polymorphism, an association be-
tween -308 polymorphism and periodontitis was not ob-
served in our study, in accordance other data [36-38]. How-
ever, a higher frequency of homozygous (G/G) genotype was 
observed in individuals with periodontitis when compared to 
controls in Egyptians [26]. Additionally, combined geno-
types composed of TNF- (-308) and lymphotoxin- (+252) 
gene polymorphisms were reported to influence the suscep-
tibility to chronic periodontitis in the Japanese population 
[39]. It has been reported that specific combinations of func-
tional polymorphisms in different genes may significantly 
alter the individual risk to development of a phenotype in a 
disease [21]. 
Considering the anti-inflammatory and inflammatory 
profiles of IL-10 and TNF-, respectively, we evaluated the 
frequency of specific combinations of functional polymor-
phisms. We determined the frequency of individuals with 
“anti-inflammatory genotype”, characterized as “low TNF- 
and high IL-10” producers, and of individuals with “inflam-
matory genotype”, characterized as “high TNF- and low 
IL-10” producers. No association was observed between 
these genotypes and the study groups. However, interper-
sonal differences in the regulation of IL-10 and TNF- pro-
duction may be critical to determine the final outcome of an 
inflammatory response and may be a consequence of occur-
rence of multiple polymorphisms in individuals. 
We have previously shown that the IL-1B (+3954) and 
IL-1A (-889) genes polymorphisms are associated with 
chronic periodontitis [18, 40] and that the IL6 (-174) poly-
morphism is associated with the severity of periodontitis [41] 
in a sample of Brazilian individuals. These data suggests that 
altered levels these cytokines may exist in these individuals 
and thus may influence the expression of other cytokines, as 
TNF- or IL-10.  
CONCLUSION 
The IL10 and TNFA gene promoter polymorphisms in-
vestigated are not associated with different clinical forms of 
periodontitis or with severity of the disease in the Brazilian 
population. Considering that little is known about the genetic 
basis of susceptibility to periodontitis in Brazilian popula-
tion, the analysis of genetic polymorphisms in a sample this 
population represents important information concerning 
periodontal disease in Brazil. Thus, information regarding 
the presence as well as a lack of association between poly-
morphisms and disease are of great interest. 
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